Captopril inhibits the production of tumor necrosis factor-α by human mononuclear cells in patients with congestive heart failure

Clinica Chimica Acta

Volumn 304, Issue 1-2, 2001, Pages 85-90

  Zhao, Shui Ping ^a   Xie, Xiao Mei ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Captopril; Congestive heart failure; Tumor necrosis factor

Indexed keywords

CAPTOPRIL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CACHEXIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; IMMUNOMODULATION; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; SUPERNATANT;

ADULT; AGED; CAPTOPRIL; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; MONOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035154235     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(00)00405-8     Document Type: Article

References (20)

1. Elevated circulating concentrations of tumor necrosis factor in severe chronic heart failure
2. Increased circulating cytokines in patients with myocarditis and cardiomyopathy
3. Circulating concentrations of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension
4. Elevated plasma concentrations of tumor necrosis factor in chronic heart failure with cachexia
5. Basic mechanisms in congestive heart failure recognizing the role of proinflammatory cytokine
6. Cytokines and cardiac contractile function
7. Increased concentrations of tumour necrosis in cachectic patients with severe chronic heart failure
8. Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure
9. Elevated tumour necrosis factor alpha of blood mononuclear cells in patients with congestive heart failure
10. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
11. Effect of enalapril on mortality in severe congestive heart failure: Results of the cooperative North Scandinavian Enalapril survival study
12. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial
13. Angiotensin-converting-enzyme inhibitors suppress synthesis of tumour necrosis factor and interleukin 1 by human peripheral blood cells
14. Captopril and immune regulation
15. Beneficial effects of captopril in acute coxsackievirus B3 murine myocarditis
16. Differential effects of captopril and enalapril, two angiotensin converting enzyme inhibitors, on immune reactivity in experimental lupus disease
17. Captopril: A new treatment for rheumatoid arthritis?
18. Tumor necrosis factor in severe congestive heart failure
19. The effect of renin-angiotensin system inhibitors on pro-and anti-inflammatory cytokine production
20. 2